Skip to main content
. Author manuscript; available in PMC: 2015 Mar 25.
Published in final edited form as: Curr Top Med Chem. 2014;14(13):1606–1618. doi: 10.2174/1568026614666140827144752

Fig. (8).

Fig. (8)

HIV-1 infection assay. HIV-1SF162 infectivity in human glial was determined based on the relative amount of Tat protein expressed by the virus using a luciferase based assay. (HA) human astrocytes, (R5) HIV-1SF162, (M) morphine at 500 nM, (MVC) maraviroc at 100 nM, (bivalent) compound 49 at 100 nM, and (NTX) naltrexone at 1500 nM. Values are absorbance ± SEM of 3 independent experiments at 18 h post-infection (*p < 0.005 vs. un-infected cells; $p < 0.05 vs. R5 HIV-1; # p <0.05 vs. opioid; p < 0.05 vs. maraviroc (MVC); §p < 0.05 vs. morphine + MVC; ^ p <0.05 vs. MVC + NTX; ^^ p <0.05 vs. morphine + MVC + NTX; Ω p <0.05 vs. bivalent) [76].